Close Menu
Home » IP Update: Recent Patents, Patent Applications Awarded to Regulus; Alnylam; Tekmira; and More

IP Update: Recent Patents, Patent Applications Awarded to Regulus; Alnylam; Tekmira; and More

Mar 15, 2012
Premium

Title: Oligomeric Compounds and Compositions for Use in Modulation of Small Non-Coding RNAs

Patent Number: 8,133,876

Filed: Dec. 30, 2008

Lead Inventor: Frank Bennett, Regulus Therapeutics

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

More Troubling Resistance

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

Many Dollar Bills There

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

'Transparency' Rule Proposed

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

Nature Papers Present Method for Simulating Hi-C Data, More

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. Researchers Develop CRISPR Method for Dose-Dependent Gene Expression Activation

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.